CHAD MERRILL: Open Payments
NPI 1265135198 · LEWISTON, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $70 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Verona Pharma, Inc. | 1 | $32 |
| Grifols USA, LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, Prolastin-C Liquid, FASENRA.
Industry payments across ME — which companies pay providers there.
